Developing muscle-specific performance measurement for elite sport
BioSensr was developed to give sports professionals a practical, field-ready way to track muscle activation during a standardised isometric hamstring hold. The platform combines flexible skin-contact sensors with intuitive software for live recording, athlete-specific baseline comparison, and historical trend analysis.
Our focus is repeatable field measurement. BioSensr tracks functional activation values and trend changes across sessions; it does not diagnose health conditions or make return-to-play determinations.
Leadership and Strategy
Jan-Willem van der Wallen (left) and Dr. Jett van der Wallen (right)
Jan-Willem (John) van der Wallen
Director & Commercial Lead
Background: Cornell University alumnus with senior executive experience.
Expertise: Corporate governance, institutional capital growth, and transaction structuring.
Role: John provides commercial leadership across corporate governance, strategic partnerships, capital strategy, and intellectual property planning. He leads BioSensr’s pilot partnerships and commercial scaling.
Dr. Jett van der Wallen
Managing Director & Technical Lead
Background: PhD in Biomedical Engineering from the University of Sydney and elite athletic experience.
Ecosystem: Alumnus of Nucleate, Incubate Accelerator, and Sydney Knowledge Hub.
Role: Jett’s background in competitive athletics and biomedical engineering drove BioSensr’s focus on practical, repeatable muscle activation measurement. He leads the development of the platform’s biosignal hardware, embedded processing, and software pipeline.
Strategic Roadmap
Short Term (0-12 months)
- Recruit 5-10 pilot teams to evaluate BioSensr in real sporting environments.
- Refine the software and hardware through pilot feedback and field testing.
- Progress international patent filings and the University of Sydney longitudinal research study.
Medium Term (2-5 years)
- Expand distribution across major Australian sporting codes and scale local manufacturing.
- Progress compliance, regulatory and quality management requirements to support wider adoption.
- Develop software data operations and evaluate expansion into North American and European markets.
Long Term (5-10 years)
- Establish BioSensr as the industry-standard platform for muscle-specific performance data in elite sport.
- Explore broader performance, research, defense, and human-movement applications as regulatory milestones are met.
- Assess strategic corporate transactions or public offerings to support continued enterprise scale.